Therapeutic Focus

Radella Pharmaceuticals

Our focus is on uncovering innovative therapeutic approaches, with a commitment to enhancing people's lives through the introduction of novel solutions that effectively address human health.

VISION

MD20 Improves Insulin Sensitivity

High-fat Diet Mouse Model

ITT % Change in Blood Glucose

Reduction in fat mass along with improvement in insulin sensitivity (ITT) supports novel MOA

ITT MD20

VISION

MD18 Improves Insulin Sensitivity

db / db Mouse Model

ITT MD18

As shown below, db / db mouse models are typically not anticipated to yield insulin sensitivity (ITT) separation, due to the severity of the disease in mice. Nevertheless, MD18 shows pronounced ITT improvement compared to control mice.